PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 9:48 AM ET

Sponsor Check › Person

EB
No photo found yet (own website and image search run after this page is viewed)

Eric Bednarski

Named as an officer, director or promoter on SEC Form D filings · MA, CA, PA, United Kingdom (as filed: X0), NY · Oct 27, 2009 → Aug 18, 2026

13deals (issuers)
$413Mreported sold
187investors
29Form D filings
2009–2026years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:20 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Eric Bednarski is listed as an executive officer and director on 29 SEC Form D filings by 13 issuers between Oct 2009 and Aug 2026. Largest by amount reported sold: MVM VI LP (Boston, MA — pooled investment fund — 2022; $259.9M reported sold to 57 investors), OptiNose, Inc. (Yardley, PA — pharmaceuticals — 2024; $35M reported sold to 23 investors), MVM IV LP (London, United Kingdom (as filed: X0) — pooled investment fund — 2014–2015; $27M reported sold to 4 investors), AccuVein Inc. (Medford, NY — other health care — 2011–2016; $23.5M reported sold to 62 investors), bioTheranostics, Inc. (San Diego, CA — other health care — 2016; $20M reported sold to 4 investors) and 8 more (all listed below).

What this means That is a lot of deals — 13 separate companies raised money with this person listed as executive officer and director, over about 17 years. Across those companies the filings report $413M sold in total.

Listed alongside David Brand (8 shared filings), Martin Edwards (7 shared filings), Bosun Hau (6 shared filings), Gregory Lumpkin (5 shared filings), Frank Lee Flautt III (4 shared filings) and 42 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Eric. Each name links to their own page.

The issuers belong to 2 sponsor groups: Prexa (2 issuers, $6.91M reported sold, 2010–2013) and Solx (2 issuers, $3.52M reported sold, 2010–2015).

What this means This person is listed across more than one sponsor team; each group page shows that team's full track record.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY) — none found.

What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.

We compared 29 public filings for Eric Bednarski and found 15 differences, 2 worth asking the sponsor about: Form D filed 125 days after the first sale; Eric Bednarski is no longer listed on the Feb 28, 2013 amendment; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Eric Bednarski has not run yet — it is joining a line of 41,145 names; searches run around the clock at the hosts' allowed rate. Searched so far: 641 names.

Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:20 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: 48 regulators (FINRA, NASAA, 37 states) — crawled Oct 24, 2026, 8:48 AM ET

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Eric Bednarski..

State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:20 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

15 differences found between the filings for Eric Bednarski — 2 worth asking about (compared 29 filings on Oct 24, 2026)

Note · Apr 29, 2011 – Sep 11, 2015

Eric Bednarski appears on 2 deals that stopped filing before reaching their target

SOLX INC (last filing Sep 11, 2015; $3,700,000 sold of $10,999,063); Prexa Pharmaceuticals Inc (last filing Apr 29, 2011; $3,257,173 sold of $7,007,173). Each has no filing in more than two years and reported under half its target sold.

What this means An issuer whose last filing is more than two years old and reported under half its target sold. The raise may have closed early or quietly stopped. Ask what happened to each.

SOLX INC — PartnerFacts page ↗Prexa Pharmaceuticals Inc — PartnerFacts page ↗
Sources
Worth asking · Jul 8, 2022 – Nov 10, 2022

Form D filed 125 days after the first sale — MVM VI LP

The filing says the first sale was Jul 8, 2022. The Form D was filed Nov 10, 2022 — 125 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 110 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Form D · Nov 10, 2022 ↗MVM VI LP — PartnerFacts page ↗
Sources
Note · Jul 7, 2017 – Jul 24, 2017

Form D filed 17 days after the first sale — Tarsa Therapeutics, Inc.

The filing says the first sale was Jul 7, 2017. The Form D was filed Jul 24, 2017 — 17 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 2 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Form D · Jul 24, 2017 ↗Tarsa Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Nov 16, 2016 – Dec 2, 2016

Form D filed 16 days after the first sale — AccuVein Inc.

The filing says the first sale was Nov 16, 2016. The Form D was filed Dec 2, 2016 — 16 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 1 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Form D · Dec 2, 2016 ↗AccuVein Inc. — PartnerFacts page ↗
Sources
Note · Oct 19, 2009 – Nov 10, 2022

14 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — MVM VI LP (latest filing Nov 10, 2022) · No amendment in the last 12 months on an offering that may still be open — Tarsa Therapeutics, Inc. (latest filing Jul 24, 2017) · No amendment in the last 12 months on an offering that may still be open — Tarsa Therapeutics, Inc. (latest filing Jan 13, 2017) · No amendment in the last 12 months on an offering that may still be open — AccuVein Inc. (latest filing Dec 2, 2016) · No amendment in the last 12 months on an offering that may still be open — bioTheranostics, Inc. (latest filing Feb 4, 2016) · and 9 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D · Nov 10, 2022 ↗MVM VI LP — PartnerFacts page ↗Form D · Jul 24, 2017 ↗Tarsa Therapeutics, Inc. — PartnerFacts page ↗
Sources
Worth asking · Apr 29, 2011 – Feb 28, 2013

Eric Bednarski is no longer listed on the Feb 28, 2013 amendment — AMPLA PHARMACEUTICALS INC

Eric Bednarski appears on the Apr 29, 2011 Form D/A (director) but not on the Feb 28, 2013 Form D/A for the same offering.

What this means People leave, and the issuer must list only current officers, directors and promoters. It is still worth asking why this person left and who replaced them.

Form D/A · Apr 29, 2011 ↗Form D/A · Feb 28, 2013 ↗Eric Bednarski — PartnerFacts page ↗AMPLA PHARMACEUTICALS INC — PartnerFacts page ↗
Sources
Note · Feb 10, 2010 – Feb 28, 2013

4 offerings changed their target amount between filings

Offering amount changed between filings — AMPLA PHARMACEUTICALS INC · Offering amount changed between filings — AccuVein Inc. · Offering amount changed between filings — AMPLA PHARMACEUTICALS INC · Offering amount changed between filings — Tarsa Therapeutics, Inc.

What this means Targets change as deals grow or shrink. Ask whether later money has the same terms.

Form D/A (earlier) · Apr 29, 2011 ↗Form D/A (later) · Feb 28, 2013 ↗AMPLA PHARMACEUTICALS INC — PartnerFacts page ↗Form D (earlier) · Aug 2, 2011 ↗
Sources
Note · Aug 2, 2011 – Dec 2, 2016

Industry group changed between filings — AccuVein Inc.

"Manufacturing" (Aug 2, 2011 to Oct 27, 2011); then "Other Health Care" (Dec 2, 2016).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · Aug 2, 2011 ↗Form D · Dec 2, 2016 ↗AccuVein Inc. — PartnerFacts page ↗
Sources
Note · Sep 13, 2022

Same name, different state: "Eric Bednarski" (TX) is a separate record

This page covers filings where the address state is MA or CA or PA or X0 or NY. A separate record, "Eric Bednarski" with address state TX, is listed on 1 filing — most recently by Neurolens, Inc. (Sep 13, 2022). Both records have filings in the same period (Sep 13, 2022).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Eric Bednarski (TX) — PartnerFacts page ↗Form D · Sep 13, 2022 ↗Neurolens, Inc. — PartnerFacts page ↗Eric Bednarski (MA,CA,PA,X0,NY) — this page ↗
Sources
Note · Aug 15, 2022

Same name, different state: "Eric Bednarski" (C9) is a separate record

This page covers filings where the address state is MA or CA or PA or X0 or NY. A separate record, "Eric Bednarski" with address state C9, is listed on 1 filing — most recently by MDxHealth SA (Aug 15, 2022). Both records have filings in the same period (Aug 15, 2022).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Eric Bednarski (C9) — PartnerFacts page ↗Form D · Aug 15, 2022 ↗MDxHealth SA — PartnerFacts page ↗Eric Bednarski (MA,CA,PA,X0,NY) — this page ↗
Sources
Note · Dec 22, 2021

Same name, different state: "Eric Bednarski" (GA) is a separate record

This page covers filings where the address state is MA or CA or PA or X0 or NY. A separate record, "Eric Bednarski" with address state GA, is listed on 1 filing — most recently by Vero Biotech Inc. (Dec 22, 2021). Both records have filings in the same period (Dec 22, 2021).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Eric Bednarski (GA) — PartnerFacts page ↗Form D · Dec 22, 2021 ↗Vero Biotech Inc. — PartnerFacts page ↗Eric Bednarski (MA,CA,PA,X0,NY) — this page ↗
Sources
Note · Jan 19, 2012 – Dec 19, 2013

Address moved from Sudbury, MA to Waltham, MA — SOLX INC

The people listed on the Jan 19, 2012 filing give Sudbury, MA; on the Dec 19, 2013 filing they give Waltham, MA.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Jan 19, 2012 ↗Form D · Dec 19, 2013 ↗SOLX INC — PartnerFacts page ↗
Sources
Note · Feb 10, 2010 – Apr 29, 2011

Address moved from La Jolla, CA to Boston, MA — AMPLA PHARMACEUTICALS INC

The people listed on the Feb 10, 2010 filing give La Jolla, CA; on the Apr 29, 2011 filing they give Boston, MA.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Feb 10, 2010 ↗Form D/A · Apr 29, 2011 ↗AMPLA PHARMACEUTICALS INC — PartnerFacts page ↗
Sources
Note · Oct 27, 2009 – Oct 8, 2010

Address moved from Boston, MA to Philadelphia, PA — Tarsa Therapeutics, Inc.

The people listed on the Oct 27, 2009 filing give Boston, MA; on the Oct 8, 2010 filing they give Philadelphia, PA.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Oct 27, 2009 ↗Form D · Oct 8, 2010 ↗Tarsa Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Oct 27, 2009 – Aug 18, 2026

Eric Bednarski is listed with 5 different address states: MA, CA, PA, X0, NY

MA on 14 filings (Oct 27, 2009 to Aug 18, 2026); CA on 2 filings (Feb 10, 2010 to Feb 4, 2016); PA on 8 filings (Oct 8, 2010 to May 20, 2024); United Kingdom (as filed: X0) on 4 filings (Sep 18, 2014 to Dec 16, 2022); NY on 1 filing (Dec 2, 2016).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Form D · Oct 27, 2009 ↗Form D · Feb 10, 2010 ↗Form D · Oct 8, 2010 ↗Form D · Sep 18, 2014 ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

3 of 23 offerings report sales commissions totalling $3,370,000; 0 report finder's fees; 1 reports proceeds to related persons totalling $423,117. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Aug 18, 2026 D/A
MVM K LP
File 021-537326
$0$0$0None listed on this filingEDGAR ↗
Jun 9, 2026 D/A
MVM J LP
File 021-537329
$0$0$0None listed on this filingEDGAR ↗
May 20, 2024 D
OptiNose, Inc.
File 021-513751
$0$0$0None listed on this filingEDGAR ↗
Dec 16, 2022 D
MVM E LP
File 021-467795
$0$0$0None listed on this filingEDGAR ↗
Dec 16, 2022 D
MVM F LP
File 021-467798
$0$0$0None listed on this filingEDGAR ↗
Nov 10, 2022 D
MVM VI LP
File 021-464501
$0$0$0None listed on this filingEDGAR ↗
Jul 24, 2017 D
Tarsa Therapeutics, Inc.
File 021-291370
$0$0$0None listed on this filingEDGAR ↗
Jan 13, 2017 D
Tarsa Therapeutics, Inc.
File 021-278462
$0$0$0None listed on this filingEDGAR ↗
Dec 2, 2016 D
AccuVein Inc.
File 021-275584
$0$0$0None listed on this filingEDGAR ↗
Jul 14, 2016 D
Tarsa Therapeutics, Inc.
File 021-266953
$0$0$0None listed on this filingEDGAR ↗
Feb 19, 2016 D
Tarsa Therapeutics, Inc.
File 021-257818
$0$0$0None listed on this filingEDGAR ↗
Feb 4, 2016 D
bioTheranostics, Inc.
File 021-256767
$1,620,000$0$0Piper Jaffray & Co. BrokerCheck CRD 665 ↗EDGAR ↗
Sep 11, 2015 D
SOLX INC
File 021-247437
$0$0$0None listed on this filingEDGAR ↗
Apr 21, 2015 D/A
MVM IV LP
File 021-224965
$190,000$0$0HUDSON PARTNERS SECURITIES LLC BrokerCheck CRD 145425 ↗
M2O PRIVATE FUND ADVISORS LLC BrokerCheck CRD 158741 ↗		EDGAR ↗
Dec 19, 2013 D
SOLX INC
File 021-208279
$0$0$0None listed on this filingEDGAR ↗
Mar 22, 2012 D
Tarsa Therapeutics, Inc.
File 021-175388
$0$0$0 (est.)None listed on this filingEDGAR ↗
Jan 19, 2012 D
SOLX INC
File 021-172171
$0$0$0 (est.)None listed on this filingEDGAR ↗
Oct 27, 2011 D/A
AccuVein Inc.
File 021-163829
$1,560,000 (est.)$0$423,117 (est.)
Repayment of loans made by two directors and one officer
Aquilo Partners, L.P. BrokerCheck CRD 114909 ↗EDGAR ↗
Apr 29, 2011 D/A
AMPLA PHARMACEUTICALS INC
File 021-96858
$0$0$0None listed on this filingEDGAR ↗
Apr 29, 2011 D
Prexa Pharmaceuticals Inc
File 021-159077
$0$0$0None listed on this filingEDGAR ↗
Apr 21, 2011 D/A
Tarsa Therapeutics, Inc.
File 021-148747
$0$0$0 (est.)None listed on this filingEDGAR ↗
Oct 27, 2010 D
SOLX INC
File 021-149659
$0$0$0 (est.)None listed on this filingEDGAR ↗
Oct 27, 2009 D
Tarsa Therapeutics, Inc.
File 021-135603
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 13

Every issuer that named Eric Bednarski on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

MK
Pooled Investment Fund

MVM K LP

London, United Kingdom (as filed: X0) · Feb 4, 2025 → Aug 18, 2026 · 2 filings
  • Aug 18, 2026 · D/A · $11,500,000 sold of Indefinite · 6 investors · min. No minimum reported · role: Executive Officer (Executive Officer of the General Partner of the Issuer) EDGAR ↗
  • Feb 4, 2025 · D · $0 sold of Indefinite · 0 investors · min. No minimum reported · role: Executive Officer (Executive Officer of the General Partner of the Issuer) EDGAR ↗

Raised $11.5M from 6 investors as of the latest filing. Eric is listed as executive officer on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

MJ
Pooled Investment Fund

MVM J LP

London, United Kingdom (as filed: X0) · Feb 4, 2025 → Jun 9, 2026 · 2 filings
  • Jun 9, 2026 · D/A · $10,030,000 sold of Indefinite · 8 investors · min. No minimum reported · role: Executive Officer (Executive Officer of the General Partner of the Issuer) EDGAR ↗
  • Feb 4, 2025 · D · $0 sold of Indefinite · 0 investors · min. No minimum reported · role: Executive Officer (Executive Officer of the General Partner of the Issuer) EDGAR ↗

Raised $10M from 8 investors as of the latest filing. Eric is listed as executive officer on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

O
Pharmaceuticals

OptiNose, Inc.

Yardley, PA · May 20, 2024
  • May 20, 2024 · D · $4,680,000 sold of $4,680,000 · 2 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $35M from 23 investors (100% of the $4.68M target) as of the latest filing. Eric is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

MF
Pooled Investment Fund

MVM F LP

London, United Kingdom (as filed: X0) · Dec 16, 2022
  • Dec 16, 2022 · D · $0 sold of Indefinite · 0 investors · min. No minimum reported · role: Director EDGAR ↗

No sales reported yet as of the latest filing. Eric is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

ME
Pooled Investment Fund

MVM E LP

London, United Kingdom (as filed: X0) · Dec 16, 2022
  • Dec 16, 2022 · D · $0 sold of Indefinite · 0 investors · min. No minimum reported · role: Director EDGAR ↗

No sales reported yet as of the latest filing. Eric is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

MV
Pooled Investment Fund

MVM VI LP

Boston, MA · Nov 10, 2022
  • Nov 10, 2022 · D · $259,925,000 sold of Indefinite · 57 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $259.9M from 57 investors as of the latest filing. Eric is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

TT
Biotechnology

Tarsa Therapeutics, Inc.

Philadelphia, PA · Oct 27, 2009 → Jul 24, 2017 · 8 filings
  • Jul 24, 2017 · D · $549,858 sold of $1,000,000 · 3 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 13, 2017 · D · $1,635,967 sold of $1,636,000 · 5 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 14, 2016 · D · $1,250,000 sold of $1,250,000 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 19, 2016 · D · $2,000,000 sold of $2,000,000 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 22, 2012 · D · $13,767,857 sold of $28,000,000 · 5 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 21, 2011 · D/A · $15,500,000 sold of $24,500,000 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 8, 2010 · D · $3,500,000 sold of $8,500,000 · 5 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 27, 2009 · D · $12,050,000 sold of $24,100,000 · 5 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $15.5M from 7 investors (100% of the $1M target) as of the latest filing. Eric is listed as director on 8 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

A
Other Health Care

AccuVein Inc.

Medford, NY · Aug 2, 2011 → Dec 2, 2016 · 3 filings
  • Dec 2, 2016 · D · $2,455,008 sold of $9,050,000 · 28 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 27, 2011 · D/A · $23,461,510 sold of $23,461,510 · 62 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 2, 2011 · D · $22,961,510 sold of $22,961,510 · 59 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $23.5M from 62 investors (100% of the $9.05M target) as of the latest filing. Eric is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

B
Other Health Care

bioTheranostics, Inc.

San Diego, CA · Feb 4, 2016
  • Feb 4, 2016 · D · $20,000,000 sold of $32,000,000 · 4 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $20M from 4 investors (63% of the $32M target) as of the latest filing. Eric is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

S
Biotechnology · group: Solx

SOLX INC

Waltham, MA · Oct 27, 2010 → Sep 11, 2015 · 4 filings
  • Sep 11, 2015 · D · $2,250,000 sold of $10,999,063 · 5 investors · min. No minimum reported · role: Director (Director of Solx, Inc. and Solx Europe Limited) EDGAR ↗
  • Dec 19, 2013 · D · $2,124,000 sold of $4,824,000 · 3 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 19, 2012 · D · $3,250,000 sold of $9,000,000 · 3 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 27, 2010 · D · $3,700,000 sold of $7,200,000 · 6 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $3.7M from 6 investors (34% of the $11M target) as of the latest filing. Eric is listed as director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

M
Pooled Investment Fund

MVM IV LP

London, United Kingdom (as filed: X0) · Sep 18, 2014 → Apr 21, 2015 · 2 filings
  • Apr 21, 2015 · D/A · $27,000,000 sold of Indefinite · 4 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
  • Sep 18, 2014 · D · $17,000,000 sold of Indefinite · 3 investors · min. No minimum reported · role: Executive Officer EDGAR ↗

Raised $27M from 4 investors as of the latest filing. Eric is listed as executive officer on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

AP
Pharmaceuticals · group: Prexa

AMPLA PHARMACEUTICALS INC

Boston, MA · Feb 10, 2010 → Apr 29, 2011 · 2 filings
  • Apr 29, 2011 · D/A · $1,467,898 sold of $2,400,000 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 10, 2010 · D · $295,271 sold of $1,200,000 · 6 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $3.65M from 6 investors (100% of the $2.4M target) as of the latest filing. Eric is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

PP
Pharmaceuticals · group: Prexa

Prexa Pharmaceuticals Inc

Boston, MA · Apr 29, 2011
  • Apr 29, 2011 · D · $3,257,173 sold of $7,007,173 · 4 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $3.26M from 4 investors (46% of the $7.01M target) as of the latest filing. Eric is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

Other pages with the same name (3)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • Eric Bednarski — GA, 1 issuer, Dec 22, 2021 → Dec 22, 2021 · no shared issuer
  • Eric Bednarski — TX, 1 issuer, Sep 13, 2022 → Sep 13, 2022 · no shared issuer
  • Eric Bednarski — Belgium (as filed: C9), 1 issuer, Aug 15, 2022 → Aug 15, 2022 · no shared issuer

People around Eric 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

DB
No photo found yet (own website and image search run after this page is viewed)
Person

David Brand

Executive Officer, Director · 8 shared filings (1 issuer)

Listed on the same filings as Eric Bednarski. Their page shows their other deals.

ME
No photo found yet (own website and image search run after this page is viewed)
Person

Martin Edwards

Director · 7 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Eric Bednarski. Their page shows their other deals.

BH
No photo found yet (own website and image search run after this page is viewed)
Person

Bosun Hau

Director, Executive Officer · 6 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Eric Bednarski. Their page shows their other deals.

GL
No photo found yet (own website and image search run after this page is viewed)
Person

Gregory Lumpkin

Executive Officer · 5 shared filings (1 issuer)

Listed on the same filings as Eric Bednarski. Their page shows their other deals.

JT
No photo found yet (own website and image search run after this page is viewed)
Person

James Tananbaum

Director · 4 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Eric Bednarski. Their page shows their other deals.

FF
No photo found yet (own website and image search run after this page is viewed)
Person

Frank Lee Flautt III

Director · 4 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Eric Bednarski. Their page shows their other deals.

LG
No photo found yet (own website and image search run after this page is viewed)
Person

Lewis Geffen

Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as Eric Bednarski. Their page shows their other deals.

RK
No photo found yet (own website and image search run after this page is viewed)
Person

Richard Kollender

Director · 4 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Eric Bednarski. Their page shows their other deals.

JL
No photo found yet (own website and image search run after this page is viewed)
Person

James D. Lackie

Director · 3 shared filings (1 issuer) · also on 10 other issuers

James D. Lackie is on 11 issuers in total — a repeat sponsor. Their page lists every one.

MR
No photo found yet (own website and image search run after this page is viewed)
Person

Matthew Rieke

Director · 3 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Eric Bednarski. Their page shows their other deals.

DA
No photo found yet (own website and image search run after this page is viewed)
Person

Douglas Adams

Executive Officer, Director · 3 shared filings (1 issuer)

Listed on the same filings as Eric Bednarski. Their page shows their other deals.

AP
No photo found yet (own website and image search run after this page is viewed)
Person

Ashleigh Palmer

Director · 3 shared filings (1 issuer)

Listed on the same filings as Eric Bednarski. Their page shows their other deals.

CG
No photo found yet (own website and image search run after this page is viewed)
Person

Christopher Gabrieli

Director · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Eric Bednarski. Their page shows their other deals.

JF
No photo found yet (own website and image search run after this page is viewed)
Person

Jason Fisherman

Director · 3 shared filings (2 issuers) · also on 2 other issuers

Listed on the same filings as Eric Bednarski. Their page shows their other deals.

CC
No photo found yet (own website and image search run after this page is viewed)
Person

Charles Cohen

Executive Officer, Director · 3 shared filings (2 issuers) · also on 2 other issuers

Listed on the same filings as Eric Bednarski. Their page shows their other deals.

RG
No photo found yet (own website and image search run after this page is viewed)
Person

Ron Goldman

Executive Officer, Director · 3 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Eric Bednarski. Their page shows their other deals.

NA
No photo found yet (own website and image search run after this page is viewed)
Person

NEIL JAMES AKHURST

Executive Officer, Director · 3 shared filings (2 issuers)

Listed on the same filings as Eric Bednarski. Their page shows their other deals.

SR
No photo found yet (own website and image search run after this page is viewed)
Person

Stephen Reeders

Executive Officer · 2 shared filings (1 issuer) · also on 18 other issuers

Stephen Reeders is on 19 issuers in total — a repeat sponsor. Their page lists every one.

JZ
No photo found yet (own website and image search run after this page is viewed)
Person

Joseph Anthony Zott

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Eric Bednarski. Their page shows their other deals.

JM
No photo found yet (own website and image search run after this page is viewed)
Person

Joseph McCormick

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Eric Bednarski. Their page shows their other deals.

JL
No photo found yet (own website and image search run after this page is viewed)
Person

Jim Largent

Director · 2 shared filings (1 issuer)

Listed on the same filings as Eric Bednarski. Their page shows their other deals.

BM
No photo found yet (own website and image search run after this page is viewed)
Person

BALAJI MURALIDHAR

Executive Officer · 2 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Eric Bednarski. Their page shows their other deals.

TC
No photo found yet (own website and image search run after this page is viewed)
Person

THOMAS THEODORE CASDAGLI

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Eric Bednarski. Their page shows their other deals.

DF
No photo found yet (own website and image search run after this page is viewed)
Person

Derek Ferguson

Director · 2 shared filings (1 issuer)

Listed on the same filings as Eric Bednarski. Their page shows their other deals.

RL
No photo found yet (own website and image search run after this page is viewed)
Person

Richard Levy

Director · 2 shared filings (1 issuer)

Listed on the same filings as Eric Bednarski. Their page shows their other deals.

HH
No photo found yet (own website and image search run after this page is viewed)
Person

Hugo Harrod

Executive Officer · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Eric Bednarski. Their page shows their other deals.

VL
No photo found yet (own website and image search run after this page is viewed)
Person

Vincent P Luciano

Executive Officer · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Eric Bednarski. Their page shows their other deals.

AS
No photo found yet (own website and image search run after this page is viewed)
Person

Alejandro Sanchez

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Eric Bednarski. Their page shows their other deals.

DK
No photo found yet (own website and image search run after this page is viewed)
Person

David Kabakoff

Director · 1 shared filing (1 issuer) · also on 11 other issuers

David Kabakoff is on 12 issuers in total — a repeat sponsor. Their page lists every one.

JW
No photo found yet (own website and image search run after this page is viewed)
Person

Jerry Wisler

Director · 1 shared filing (1 issuer)

Listed on the same filings as Eric Bednarski. Their page shows their other deals.

JH
No photo found yet (own website and image search run after this page is viewed)
Person

James Hauske

Executive Officer, Director · 1 shared filing (1 issuer)

Listed on the same filings as Eric Bednarski. Their page shows their other deals.

TN
No photo found yet (own website and image search run after this page is viewed)
Person

Thomas Needham

Executive Officer, Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Eric Bednarski. Their page shows their other deals.

EG
No photo found yet (own website and image search run after this page is viewed)
Person

Evelyn Graham

Executive Officer, Director · 1 shared filing (1 issuer)

Listed on the same filings as Eric Bednarski. Their page shows their other deals.

BP
No photo found yet (own website and image search run after this page is viewed)
Person

Brian Piper

Director · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as Eric Bednarski. Their page shows their other deals.

MM
No photo found yet (own website and image search run after this page is viewed)
Person

Michael F. Marino

Executive Officer · 1 shared filing (1 issuer) · also on 4 other issuers

Michael F. Marino is on 5 issuers in total — a repeat sponsor. Their page lists every one.

RM
No photo found yet (own website and image search run after this page is viewed)
Person

Ramy A. Mahmoud

Director, Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Eric Bednarski. Their page shows their other deals.

KM
No photo found yet (own website and image search run after this page is viewed)
Person

Kevin McMahon

Executive Officer, Director · 1 shared filing (1 issuer)

Listed on the same filings as Eric Bednarski. Their page shows their other deals.

NB
No photo found yet (own website and image search run after this page is viewed)
Person

Nicholas Barthelemy

Executive Officer, Director, Promoter · 1 shared filing (1 issuer)

Listed on the same filings as Eric Bednarski. Their page shows their other deals.

FF
No photo found yet (own website and image search run after this page is viewed)
Person

Frank Flaut III

Director · 1 shared filing (1 issuer)

Listed on the same filings as Eric Bednarski. Their page shows their other deals.

SH
No photo found yet (own website and image search run after this page is viewed)
Person

Sandra L. Helton

Director · 1 shared filing (1 issuer)

Listed on the same filings as Eric Bednarski. Their page shows their other deals.

The team behind the deals

P
Sponsor group

Prexa

2 issuers · 4 filings · $6.91M reported sold · 2010–2013

One team, 2 deal companies. Eric Bednarski is listed on 2 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Eric Bednarski.

S
Sponsor group

Solx

2 issuers · 5 filings · $3.52M reported sold · 2010–2015

One team, 2 deal companies. Eric Bednarski is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Eric Bednarski.

Same business address

11 other issuers file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Business registration (state registry / Secretary of State)

Individuals are not matched to business registrations — registries list companies, and a name alone is not enough to tie a person to one. Officers and managers appear by name inside each matched company's record on the issuer pages. Registries searched: AL (Alabama Secretary of State — Business Entity Records (arc-sos.state.al.us), searched by issuer name, data as of Oct 24, 2026); CO (Colorado Secretary of State — Business Entities in Colorado (data.colorado.gov), data as of Oct 23, 2026); CT (Connecticut Secretary of the State — Business Registry (data.ct.gov), data as of Oct 24, 2026); FL (Florida Department of State, Division of Corporations — quarterly corporate data file (Sunbiz), data as of Oct 7, 2026); NY (New York Department of State — Corporations and Other Entities (data.ny.gov: All Filings + Active Corporations), data as of Oct 20, 2026); OR (Oregon Secretary of State — Active Businesses, All (data.oregon.gov), data as of Oct 20, 2026); PA (Pennsylvania Department of State — Registered Businesses, Current (data.pa.gov), data as of Oct 6, 2026); TX (Texas Comptroller — Active Franchise Taxpayers incl. Secretary of State file data (data.texas.gov), data as of Oct 24, 2026). Registries of other states have not been searched: many publish no bulk file and require a CAPTCHA or bot challenge on their search page, which we do not bypass (Delaware, for example, offers no public bulk file).

Adviser registration (Form ADV)

None of the 13 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Eric Bednarski by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 13 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Eric Bednarski is listed on: none on file. No website or social profile named in MVM VI LP's SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #140,169 of 374,652 in line (1,386 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Boston, MA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗Massachusetts MassCourts ↗California — find the county court ↗Los Angeles Superior Court case search ↗Pennsylvania UJS portal case search ↗New York WebCivil Supreme ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

Massachusetts Secretary of State business search ↗California Secretary of State business search ↗Pennsylvania Secretary of State business search ↗New York Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Eric Bednarski appears on a new Form D, or when a court case or SEC action is matched to them. See plans →